FortuneIndia

Quick Links :

Fortune 500 India
40 Under 40
Most Powerful Women
Budget 2024
India's Richest
The Next 500
Best B-Schools
Opinion
First Edit
Multimedia
Events

Fortune 500 India
40 Under 40
Most Powerful Women
The Next 500
Best B-Schools
All Rankings
Events
Macro
Enterprise
Technology
Reviews
Venture
Investing
Multimedia
Fortune India Exchange
Bystander
Opinion
Infographics
Ideas
Long Reads
People
Buy on Amazon
Polemicist
Annual Subscription

bs7

Share

March 2024

Emission control technology far exceeds what's required: Corning's Willard Cutler

Emission control technology far exceeds what's required: Corning's Willard Cutler

One old vehicle pollutes as much as 50 new vehicles, says Willard Cutler

By Karan Dhar

Advertisement

Top Stories

Awfis IPO to open on May 22; price band at ₹364-383 apiece

Awfis IPO to open on May 22; price band at ₹364-383 apiece

Oil, gold imports drive up India's trade deficit in April

Oil, gold imports drive up India's trade deficit in April

Soon, you can control the iPhone with your eyes

Soon, you can control the iPhone with your eyes

Brookfield India REIT acquires 50% stake in Bharti Enterprises’ 4 marquee assets for ₹6,000 cr

Brookfield India REIT acquires 50% stake in Bharti Enterprises’ 4 marquee assets for ₹6,000 cr

Mankind Pharma shares rise up to 5% on strong Q4, fundraising plan

Mankind Pharma shares rise up to 5% on strong Q4, fundraising plan

Advertisement

Advertisement

Top Stories

Awfis IPO to open on May 22; price band at ₹364-383 apiece

Awfis IPO to open on May 22; price band at ₹364-383 apiece

Oil, gold imports drive up India's trade deficit in April

Oil, gold imports drive up India's trade deficit in April

Soon, you can control the iPhone with your eyes

Soon, you can control the iPhone with your eyes

Brookfield India REIT acquires 50% stake in Bharti Enterprises’ 4 marquee assets for ₹6,000 cr

Brookfield India REIT acquires 50% stake in Bharti Enterprises’ 4 marquee assets for ₹6,000 cr

Mankind Pharma shares rise up to 5% on strong Q4, fundraising plan

Mankind Pharma shares rise up to 5% on strong Q4, fundraising plan

Advertisement

Contact Us
Vision & Core Values
Terms of Use
Privacy & Cookie Policy

Powered by Quintype